Eric Dengelegi

Eric Dengelegi is a regulatory affairs professional with extensive experience in preparing regulatory submissions and developing strategies for compliance across various markets. Currently serving as a Regulatory Affairs Specialist at OrganOx since March 2024, Eric is responsible for submissions to the FDA and Health Canada. Prior experience includes consulting at RQM+ from October 2021 to March 2024, where Eric authored EU MDR compliant documentation and evaluated product classifications. Additionally, Eric has held regulatory roles at Neuronetics, Inc., and Integra LifeSciences, focusing on compliance and submission strategies for international markets. Earlier career experience at the Musculoskeletal Transplant Foundation involved overseeing production activities and ensuring quality standards. Eric holds a Master of Science in Exercise Physiology from Kean University and a Bachelor of Science in Biology from Ramapo College of New Jersey.